Cue Biopharma
55 hedge funds and large institutions have $12.8M invested in Cue Biopharma in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 7 closing their positions.
Holders
55
Holders Change
+5
Holders Change %
+10%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
19
Reduced
5
Closed
7
Calls
$47K
Puts
$8K
Net Calls
+$39K
Net Calls Change
+$23K
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$688K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$354K |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$227K |
| 4 |
4
BlackRock
New York
|
$696K |
| 5 |
HF
5
HRT Financial
New York
|
$53K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Fidelity Investments
Boston,
Massachusetts
| $105 | 96 | -189 | -66% |
|
|
PD
52
Point72 (DIFC)
Dubai,
United Arab Emirates
| $72 | 66 | +8 | +14% |
|
|
SFG
53
Stonebridge Financial Group
Wormleysburg,
Pennsylvania
| $68 | 62 | +62 | New |
|
54
Citigroup
New York
| $47 | 43 | – | – |
|
|
SS
55
SBI Securities
Tokyo,
Japan
| $1 | 1 | +1 | New |
|
|
SPC
56
Slate Path Capital
New York
| – | – | -2,402,455 | Closed |
|
57
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -24,672 | Closed |
|
58
Dimensional Fund Advisors
Austin,
Texas
| – | – | -14,575 | Closed |
|
|
LCGC
59
Legacy Capital Group California
Los Gatos,
California
| – | – | -10,000 | Closed |
|
|
CFM
60
Catalyst Funds Management
Sydney NSW,
Australia
| – | – | -9,000 | Closed |
|
|
HI
61
Harbour Investments
Madison,
Wisconsin
| – | – | -439 | Closed |
|
|
AAP
62
Arax Advisory Partners
Denver,
Colorado
| – | – | -215 | Closed |
|
63
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|
|
CFGS
64
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
65
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|